WilmerHale Advises PTC Therapeutics in Strategic Financing Collaboration with Blackstone

WilmerHale Advises PTC Therapeutics in Strategic Financing Collaboration with Blackstone

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
We guide clients through today’s ever-changing debt markets, representing them in a broad variety of debt deals that range from complex financial structures to traditional loan transactions.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Offering a sophisticated, full-service solution to private equity sponsors and entrepreneurs, from initial investment to exit.

On October 27, 2022, PTC Therapeutics, Inc., a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines for patients with rare disorders, announced that it has entered into a strategic financing collaboration with Blackstone for up to $1 billion in funding. The collaboration, which provides PTC with an initial $500 million commitment, will support PTC's mission to bring transformative medicines to patients by accelerating its pipeline and business development opportunities.

The WilmerHale team advising PTC Therapeutics was led by Brian Johnson and George Shuster and included Nathan Moore, Hilary Baker-Jennings, Jana Lama and Emily Powers.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel